Home › Trial NCT01232374
Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma
- Trial IDNCT01232374
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorBiotech Pharmaceutical Co., Ltd.
- Enrollment144
- Start date2010-09
- ConditionsSquamous Cell Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.